Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Impact of transcranial direct current stimulation on fatigue in multiple sclerosis.
Benefits versus risks of latest therapies in multiple sclerosis: a perspective review.
The association between multiple sclerosis and fracture risk.
What is Susac syndrome? - A brief review of articles.
SPECIFIC TARGETING OF THE IL-23 RECEPTOR USING A NOVEL SMALL PEPTIDE NON-COMPETITIVE ANTAGONIST, DECREASES THE INFLAMMATORY RESPONSE.
Ciglitazone, a peroxisome proliferator-activated receptor gamma ligand, inhibits proliferation and differentiation of th17 cells.
Isolated dysphagia due to aquaporin-4 autoimmunity.
We know how to prescribe natalizumab for multiple sclerosis, but do we know how to withdraw it?
Prenylated Flavonoids from Cudrania tricuspidata Suppress Lipopolysaccharide-Induced Neuroinflammatory Activities in BV2 Microglial Cells.
Present and Future Therapies in Neuromyelitis Optica Spectrum Disorders.
Boswellic acids reduce TH17 differentiation via blockade of IL-1β-Mediated IRAK1 signaling.
Is there any relation between chronic cerebrospinal venous insufficiency and multiple sclerosis? - a critical review.
Detection of olfactory dysfunction using olfactory event related potentials in young patients with multiple sclerosis.
Adverse events after endovascular treatment of chronic cerebro-spinal venous insufficiency (CCSVI) in patients with multiple sclerosis.
Distinct modulation of human myeloid and plasmacytoid dendritic cells by anandamide in multiple sclerosis.
Differences between users and non-users of complementary and alternative medicine among people with multiple sclerosis in Denmark: A comparison of descriptive characteristics.
[Alemtuzumab is a new drug based on monoclonal antibodies for treatment multiple sclerosis: treatment possibilities and risks(review)].
Clinical outcomes of sacral neuromodulation in patients with neurologic conditions.
Childhood body mass index and multiple sclerosis risk: a long-term cohort study.
BACH2 represses effector programs to stabilize T(reg)-mediated immune homeostasis.
Conjugal multiple sclerosis in Isfahan, Iran: a population-based study.
The diagnosis of chronic inflammatory demyelinating polyneuropathy: a Delphi-method approach.
Cerebrospinal fluid analysis in the context of CNS demyelinating diseases.
T cell-depleted splenocytes from mice pre-immunized with neuroantigen in incomplete Freund's adjuvant involved in protection from experimental autoimmune encephalomyelitis.
Impaired functional integration in multiple sclerosis: a graph theory study.
Pages
« first
‹ previous
…
548
549
550
551
552
553
554
555
556
…
next ›
last »